An Amphibian Metamorphosis Assay Dietary Restriction Study: Lessons for Data Interpretation

Area of Science:

• Environmental Toxicology
• Endocrinology
• Chemical Safety Assessment

Background:

• The amphibian metamorphosis assay (AMA) is a standard in vivo screen for thyroid activity.
• Current AMA guidelines consider thyroid histopathology changes indicative of thyroid activity, regardless of other endpoints.

Purpose of the Study:

• To assess the specificity of AMA endpoints for determining thyroid activity.
• To evaluate if non-chemical factors can influence AMA results, particularly thyroid histopathology.

Main Methods:

• An AMA study was performed using five different feeding rations (50% to 5% of recommended).
• Biological endpoints including growth, development, and thyroid/liver histopathology were evaluated.
• The specificity of histopathological findings was assessed against other biological markers.

Main Results:

• Reduced feeding rations caused dose-dependent effects on development, body weight, and liver condition.
• Thyroid follicular cell hyperplasia/hypertrophy decreased, and atrophy increased with feed reduction.
• Histopathological changes in the thyroid were observed without chemical exposure, indicating non-chemical factors can induce these effects.

Conclusions:

• Treatment-related histopathological changes in AMA are not always specific to chemical-induced thyroid endocrine activity.
• Non-chemical factors, such as feed reduction, can mimic or induce thyroid-related histopathology.
• AMA interpretation requires concurrent evidence from growth and development endpoints to confirm thyroid endocrine activity.